Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2025-04-23 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
2024年度年审会计师履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the annual audit firm for the year 2024 for the company 大博医疗科技股份有限公司. It details the qualifications, independence, quality management, and audit work plan of the auditing firm 天健会计师事务所 for the 2024 annual audit. The content focuses on the audit firm's performance and compliance during the annual audit process rather than presenting the full annual report or financial statements. The document length is 2943 characters, which is relatively short and does not contain actual financial statements or comprehensive financial data. It is a standalone audit-related report assessing the auditor's performance and independence, which fits the definition of an Audit Report / Information (AR). It is not an Annual Report (10-K) or an Interim Report (IR) because it lacks substantive financial data and is not a full company report. It is not a Regulatory Filing (RNS) because it is a detailed evaluation report rather than a certification or brief announcement. Therefore, the best classification is AR with high confidence. FY 2024
2025-04-23 Chinese
关于2024年度日常关联交易确认及2025年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the confirmation of daily related-party transactions for the fiscal year 2024 and the forecast of such transactions for 2025 by the company 大博医疗科技股份有限公司. It includes transaction amounts, categories, related parties, pricing principles, and approvals by the board, independent directors, and supervisory board. The document is a regulatory announcement about related-party transactions, which is a common disclosure for listed companies to comply with stock exchange rules. It does not contain financial statements or comprehensive financial performance data, nor is it a report like an annual or interim report. It is not a voting result, management change, or earnings release. It is a regulatory filing disclosing related-party transactions and their approval status. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (7373 characters) and content confirm it is a full announcement, not a brief notice or report publication announcement.
2025-04-23 Chinese
2025年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions passed at the 2025 first extraordinary general meeting (临时股东大会) of the company. It details the meeting date, attendance, voting results on various proposals, and includes a legal opinion on the meeting's validity. There is no financial data or report content, only the official voting results and meeting details. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2602 characters), consistent with a voting results announcement rather than a full report or presentation.
2025-04-09 Chinese
福建天衡联合律师事务所关于大博医疗科技股份有限公司2025年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, voting procedures, and results of the 2025 first extraordinary general meeting (临时股东大会) of Dabao Medical Technology Co., Ltd. It details the legality and validity of the meeting and its resolutions, including election of independent directors and approval of financing proposals. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholder meeting process and outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and validates the shareholder meeting proceedings.
2025-04-09 Chinese
关于2025年度公司申请银行综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's application for a comprehensive bank credit facility for the year 2025. It details the credit limits requested from various banks and the authorization given to the chairman to handle related matters. The document is short (800 characters) and does not contain financial statements or detailed financial analysis. It is an update on financing activities, specifically about credit facilities, which fits the category of Capital/Financing Update (CAP).
2025-03-24 Chinese
独立董事提名人声明与承诺（林红珍）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment from the nominating party regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with laws and regulations, and independence criteria of the nominee. There is no financial data, no report of financial performance, no voting results, no management changes announcement, and no mention of any meeting or shareholder vote results. The document is a nomination statement related to board composition but does not announce a change or appointment itself. It is a regulatory disclosure related to board nominations and compliance with listing rules. This fits best under Board/Management Information (MANG) as it concerns board director nomination information and related compliance statements.
2025-03-24 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.